Logotype for Dolby Laboratories Inc

Dolby Laboratories (DLB) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Dolby Laboratories Inc

Q2 2025 earnings summary

24 Dec, 2025

Executive summary

  • Q2 2025 revenue reached $370M, up 1% year-over-year, driven by licensing growth in mobile and automotive, offset by lower broadcast and CE recoveries.

  • Non-GAAP net income rose to $131M ($1.34/share), while GAAP net income was $92M ($0.94/share), both down from prior year; non-GAAP EPS increased 5% year-over-year.

  • Strong engagement and momentum in automotive, mobile, and TV ecosystems, with new partnerships and product launches, including Dolby Atmos and Vision in major events and devices.

  • Cash flow from operations increased to $281.7M year-to-date, supporting dividends and share repurchases.

  • The business remains resilient despite macroeconomic uncertainty, focusing on long-term growth drivers.

Financial highlights

  • Licensing revenue grew 2% year-over-year to $346M, with mobile and automotive offsetting declines in broadcast and CE; product and services revenue was $23.6M, down 10% year-over-year.

  • Operating income for Q2 was $107.8M, nearly flat year-over-year.

  • Cash and investments totaled $701M at quarter end; cash and equivalents were $626.6M.

  • Dividend declared at $0.33 per share, up 10% from last year.

  • Share repurchases totaled $35M in Q2; $352M remains authorized.

Outlook and guidance

  • Full-year 2025 revenue guidance revised to $1.31B–$1.38B; licensing revenue $1.21B–$1.28B.

  • Q3 2025 revenue expected between $290M–$320M; licensing revenue $265M–$295M.

  • Full-year non-GAAP EPS expected between $3.88–$4.03; GAAP EPS $2.31–$2.46.

  • Non-GAAP operating expenses for the year projected at $760M–$775M.

  • Gross margin for Q3 expected at approximately 88% (non-GAAP); full-year gross margin ~87% GAAP, ~90% non-GAAP.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more